PL367308A1 - Novel use - Google Patents

Novel use

Info

Publication number: PL367308A1
Authority: PL; Poland
Prior art keywords: novel use; novel
Prior art date: 2001-05-18

Application number

PL02367308A

Other languages

Polish (pl)

Inventor

Douglas William Pierre Hay

Gareth John Sanger

Tadataka Yamada

Original Assignee

Smithkline Beecham Corporation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-05-18

Filing date

2002-05-17

Publication date

2005-02-21

2001-05-18 Priority claimed from GB0112208A external-priority patent/GB0112208D0/en

2001-12-06 Priority claimed from GB0129268A external-priority patent/GB0129268D0/en

2002-05-17 Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation

2005-02-21 Publication of PL367308A1 publication Critical patent/PL367308A1/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Neurology (AREA)
Physical Education & Sports Medicine (AREA)
Nutrition Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Peptides Or Proteins (AREA)

PL02367308A 2001-05-18 2002-05-17 Novel use PL367308A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB0112208A GB0112208D0 (en)	2001-05-18	2001-05-18	New use
GB0129268A GB0129268D0 (en)	2001-12-06	2001-12-06	Novel use

Publications (1)

Publication Number	Publication Date
PL367308A1 true PL367308A1 (en)	2005-02-21

Family

ID=26246093

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL02367308A PL367308A1 (en)	2001-05-18	2002-05-17	Novel use

Country Status (19)

Country	Link
EP (1)	EP1387687A4 (en)
JP (1)	JP2004534761A (en)
KR (1)	KR20040016865A (en)
CN (1)	CN1269483C (en)
AR (1)	AR045879A1 (en)
AU (1)	AU2002303811B2 (en)
BR (1)	BR0209662A (en)
CA (1)	CA2447063A1 (en)
CZ (1)	CZ20033115A3 (en)
HU (1)	HUP0400966A2 (en)
IL (1)	IL158701A0 (en)
MX (1)	MXPA03010509A (en)
MY (1)	MY134211A (en)
NO (1)	NO20035121L (en)
NZ (1)	NZ529462A (en)
PE (1)	PE20021067A1 (en)
PL (1)	PL367308A1 (en)
TW (1)	TWI243678B (en)
WO (1)	WO2002094187A2 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7772188B2 (en)	2003-01-28	2010-08-10	Ironwood Pharmaceuticals, Inc.	Methods and compositions for the treatment of gastrointestinal disorders
DE602004028678D1 (en)	2003-01-28	2010-09-23	Ironwood Pharmaceuticals Inc	Compositions for the treatment of gastrointestinal disorders
PE20060161A1 (en) *	2004-03-30	2006-05-10	Smithkline Beecham Corp	SPRAY DRIED PHARMACEUTICAL COMPOSITIONS INCLUDING TALNETANT
WO2005100997A2 (en) *	2004-04-16	2005-10-27	Bayer Healthcare Ag	Diagnostics and therapeutics for diseases associated with tachykinin receptor 3 (tacr3)
US20080255193A1 (en) *	2005-09-30	2008-10-16	Jeffrey Brum	Pharmaceutical Composition
TW200804288A (en)	2005-12-12	2008-01-16	Astrazeneca Ab	Alkylsulphonamide quinolines
US8969514B2 (en)	2007-06-04	2015-03-03	Synergy Pharmaceuticals, Inc.	Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
WO2008151257A2 (en)	2007-06-04	2008-12-11	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8034782B2 (en)	2008-07-16	2011-10-11	Synergy Pharmaceuticals, Inc.	Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2810951B1 (en)	2008-06-04	2017-03-15	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2018129556A1 (en)	2017-01-09	2018-07-12	Ardelyx, Inc.	Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
NO2384318T3 (en)	2008-12-31	2018-04-14
KR200452372Y1 (en) *	2010-05-14	2011-02-22	서일수	Communication line support device of construction lift
KR101034774B1 (en) *	2010-07-30	2011-05-17	(주)챔피온코리아	Lift device using wire rope
US9616097B2 (en)	2010-09-15	2017-04-11	Synergy Pharmaceuticals, Inc.	Formulations of guanylate cyclase C agonists and methods of use
MX366293B (en)	2012-08-21	2019-07-04	Ardelyx Inc	Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders.
US10376481B2 (en)	2012-08-21	2019-08-13	Ardelyx, Inc.	Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US9708367B2 (en)	2013-03-15	2017-07-18	Synergy Pharmaceuticals, Inc.	Agonists of guanylate cyclase and their uses
AU2014235209B2 (en)	2013-03-15	2018-06-14	Bausch Health Ireland Limited	Guanylate cyclase receptor agonists combined with other drugs
EP3552630A1 (en)	2013-04-12	2019-10-16	Ardelyx, Inc.	Nhe3-binding compounds for inhibiting phosphate transport
CA2909752A1 (en)	2013-04-19	2014-10-23	Astrazeneca Ab	A nk3 receptor antagonist compound (nk3ra) for use in a method for the treatment of polycystic ovary syndrome (pcos)
CN105764916B (en)	2013-06-05	2021-05-18	博士医疗爱尔兰有限公司	Ultrapure agonists of guanylate cyclase C, methods of making and using the same
US11242337B2 (en)	2017-01-09	2022-02-08	Ardelyx, Inc.	Compounds useful for treating gastrointestinal tract disorders
BR112019013963A2 (en)	2017-01-09	2020-04-28	Ardelyx Inc	nhe-mediated antiport inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2719311B1 (en) *	1994-03-18	1998-06-26	Sanofi Sa	Compounds that are selective antagonists of the human NK3 receptor and their use as drugs and diagnostic tools.
US5434158A (en) *	1994-04-26	1995-07-18	Merck & Co., Inc.	Spiro-substituted azacycles as neurokinin-3 antagonists
AR004735A1 (en) *	1995-11-24	1999-03-10	Smithkline Beecham Spa	CHINOLEIN 4-AMIDO SUBSTITUTED, A PROCEDURE FOR ITS PREPARATION, A PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM AND THE USE OF THE SAME FOR THE PREPARATION OF A MEDICINAL PRODUCT.
CA2291111A1 (en) *	1997-05-23	1998-11-26	Giuseppe Arnaldo Maria Giardina	Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists
AR021354A1 (en) *	1998-11-20	2002-07-17	Smithkline Beecham Spa	PROCEDURE FOR THE PREPARATION OF A QUINOLINE DERIVATIVE COMPOUND AND A PROCEDURE TO PREPARE A PHARMACEUTICAL COMPOSITION

2002
- 2002-05-16 MY MYPI20021787A patent/MY134211A/en unknown
- 2002-05-17 NZ NZ529462A patent/NZ529462A/en unknown
- 2002-05-17 IL IL15870102A patent/IL158701A0/en unknown
- 2002-05-17 HU HU0400966A patent/HUP0400966A2/en unknown
- 2002-05-17 PE PE2002000415A patent/PE20021067A1/en not_active Application Discontinuation
- 2002-05-17 PL PL02367308A patent/PL367308A1/en not_active Application Discontinuation
- 2002-05-17 CZ CZ20033115A patent/CZ20033115A3/en unknown
- 2002-05-17 MX MXPA03010509A patent/MXPA03010509A/en not_active Application Discontinuation
- 2002-05-17 CA CA002447063A patent/CA2447063A1/en not_active Abandoned
- 2002-05-17 AU AU2002303811A patent/AU2002303811B2/en not_active Ceased
- 2002-05-17 WO PCT/US2002/015911 patent/WO2002094187A2/en not_active Ceased
- 2002-05-17 JP JP2002590908A patent/JP2004534761A/en active Pending
- 2002-05-17 BR BR0209662-5A patent/BR0209662A/en not_active IP Right Cessation
- 2002-05-17 KR KR10-2003-7014960A patent/KR20040016865A/en not_active Withdrawn
- 2002-05-17 CN CNB028101588A patent/CN1269483C/en not_active Expired - Fee Related
- 2002-05-17 EP EP02731870A patent/EP1387687A4/en not_active Withdrawn
- 2002-05-17 AR ARP020101845A patent/AR045879A1/en not_active Application Discontinuation
- 2002-05-17 TW TW091110318A patent/TWI243678B/en active
2003
- 2003-11-17 NO NO20035121A patent/NO20035121L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
IL158701A0 (en)	2004-05-12
PE20021067A1 (en)	2003-02-02
AU2002303811B2 (en)	2005-07-07
CN1509175A (en)	2004-06-30
KR20040016865A (en)	2004-02-25
CZ20033115A3 (en)	2004-09-15
BR0209662A (en)	2004-04-20
WO2002094187A2 (en)	2002-11-28
CA2447063A1 (en)	2002-11-28
EP1387687A4 (en)	2006-07-05
NO20035121D0 (en)	2003-11-17
AR045879A1 (en)	2005-11-16
WO2002094187A3 (en)	2003-05-30
MY134211A (en)	2007-11-30
NO20035121L (en)	2003-11-17
CN1269483C (en)	2006-08-16
EP1387687A2 (en)	2004-02-11
JP2004534761A (en)	2004-11-18
MXPA03010509A (en)	2004-03-02
TWI243678B (en)	2005-11-21
HUP0400966A2 (en)	2004-08-30
NZ529462A (en)	2005-07-29

Publication	Publication Date	Title
IL158517A0 (en)	2004-05-12	Novel 4-anilinoquinoline-3-carboxamides
EP1387687A4 (en)	2006-07-05	Novel use
GB0125088D0 (en)	2001-12-12	New use
GB0115181D0 (en)	2001-08-15	Novel use
GB0100762D0 (en)	2001-02-21	Novel use
GB0104554D0 (en)	2001-04-11	New uses
EG23036A (en)	2004-01-31	Novel pyrrolecarboxamides
GB0106031D0 (en)	2001-05-02	Use
PL364076A1 (en)	2004-12-13	Novel pyridylmethylaminopyrimidines
PL367864A1 (en)	2005-03-07	Novel combination
GB0119920D0 (en)	2001-10-10	New use
GB0119022D0 (en)	2001-09-26	Novel use
GB0129268D0 (en)	2002-01-23	Novel use
GB0118919D0 (en)	2001-09-26	Novel use
GB0129266D0 (en)	2002-01-23	Novel use
GB0100852D0 (en)	2001-02-21	Novel use
GB0108115D0 (en)	2001-05-23	Use
GB0103892D0 (en)	2001-04-04	Use
GB0103899D0 (en)	2001-04-04	Use
GB0102482D0 (en)	2001-03-14	Use
GB0126186D0 (en)	2002-01-02	Use
GB0129834D0 (en)	2002-01-30	New use
GB0115598D0 (en)	2001-08-15	New use
GB0115989D0 (en)	2001-08-22	New use
GB0112208D0 (en)	2001-07-11	New use

Legal Events

Date	Code	Title	Description
2011-02-28	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)